What clinical and economic lessons can foreign markets learn from the U.S. about GLP-1s? More than you might think. Omada CEO Sean Duffy explored this topic in a piece written in collaboration with the World Economic Forum to coincide with his participation at the annual meeting in hashtag#Davos. Read his takeaways here: https://lnkd.in/ezDVprbp
Weight management is not just about numbers on a scale; it's a deeply personal journey that can be fraught with emotional hurdles. That’s why we want to understand our member experience. In a recent Omada Insights Lab analysis, our team found that many members discontinue taking GLP-1s for weight loss due to access barriers, not because they achieved their goal weight. How can we support these members? We found they want a highly specialized companion program that provides human support and behavioral health content. Learn more: https://lnkd.in/eMaRwkhf
New Proof Points edition, and new location! Omada’s clinical newsletter has moved to our company account. In our first edition of the year, Omada Clinical Research Scientist Susan Devaraj PhD, RD reflects on early GLP-1 outcomes data from Omada Insights Lab, and the importance of redefining success in GLP-1 treatment programs. Dive in, share and subscribe!
Let’s hear it for Lily Orn, named our Commercial team’s 2024 Master Ambassador. Her strong cross-functional partnerships and leadership in the member growth marketing team are crucial for the team’s success. Thanks for all you do, Lily! 🧡
An exceptional leader with a steadfast dedication to her team, we’d like to congratulate the Commercial Team Manager of 2024, Julia DiMartinis. Thank you for what you do, Julia! We appreciate you. 🧡
It’s awards season and we’d like to honor the amazing Omada Commercial team members! With exceptional performance in supporting and empowering our customers and delivering results, the Commercial team’s Partner Powerhouse for 2024 is Beth (Riphagen) Goodwin! Thank you for embodying Omada’s values, Beth! 👏
🥁 And the Commercial Omadan of the Year goes to … Michelle Percia! She stands out from the crowd in her dedication and thoughtfulness. Her involvement in so many initiatives and an ability to connect the dots, ask thoughtful questions, and take initiatives from idea to completion in a blink of an eye is always impressive. Let’s hear a round of applause for Michelle! 👏
A big shout out to Dane Woodley! As the master of analogies, the king of creativity, and the tr-AI-lblazer of productivity, he is the Commercial team’s 2024 Most Valuable Supporter. We’re so lucky to have you, Dane! 🙏
A team player across functions, a great attitude, and a calm in the chaos, Bhupendra Patel is our Commercial team’s 2024 Foundation Builder. Let’s give a round of applause for all he’s done to help his team, and Omada, succeed! Thank you 👏
🚨 Omada Health released findings from a survey of 1,000 consumers using GLP-1s for weight loss. Key highlights include: 🔍 Only 18% of those who discontinued GLP-1s achieved their weight loss goals, indicating unmet needs in long-term support. 💸 Access and cost challenges significantly impact medication persistence, with many facing barriers to continued use. These insights emphasize the importance of support beyond medication. Learn more about our findings: https://lnkd.in/eUY3Z5EY
